Validation of the French Version of the New Mobility Score (NMS) (MOB-SCORE)
Validation of the French Version of the New Mobility Score (NMS) in Hospitalized Patients With Hip Fracture
The incidence of hip fractures in France is 50,000 cases per year among women and 16,000 among men, with a 1-year mortality rate of 20-24%. After a fracture, 10-30% of patients become functionally dependent. The increasing aging of the population and the rise in dependency are likely to worsen the situation of older patients in hospital settings.
Several tools are available to assess functional independence, including the New Mobility Score (NMS), which evaluates mobility through three domains: mobility indoors, mobility outdoors, and shopping activities. The NMS has shown good performance in predicting patient mortality and functional recovery, and its use is recommended in clinical practice. However, the French version of the NMS has not yet been validated.
The French validation of the NMS is important to facilitate its implementation in clinical practice and research, particularly because of its simplicity and the need for rapid assessment tools for healthcare professionals. A French version of the NMS has been translated, and the MOB-SCORE study aims to assess its reliability and validity among healthcare professionals caring for patients with hip fractures.
연구 개요
연구 유형
등록 (추정된)
연락처 및 위치
연구 연락처
- 이름: Olivia FEBVEY-COMBES, MD
- 전화번호: +33 (0)4 72 11 51 62
- 이메일: olivia.febvey-combes@chu-lyon.fr
연구 장소
-
-
-
Lyon, 프랑스, 69004
- 모병
- Service I3 de court séjour gériatrique, Hôpital de la Croix-Rousse, Hospices Civils de Lyon
-
연락하다:
- Iago HUGHES SANMARTIN, Physiotherapist
- 전화번호: +33 (0)4 26 10 94 75
- 이메일: Iago.hughes-sanmartin@chu-lyon.fr
-
수석 연구원:
- Iago HUGHES SANMARTIN, Physiotherapist
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 고령자
건강한 자원 봉사자를 받아들입니다
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- Patients aged 75 years and older admitted to a hospital department following a hip fracture and treated surgically (osteosynthesis or arthroplasty).
- Type of fracture: pertrochanteric fracture or femoral neck fracture.
- Sufficient proficiency in French to complete the questionnaires.
- Patients affiliated with a health insurance scheme.
- No objection to participate from the patient or the caregiver in case of cognitive impairment.
Exclusion Criteria: no exclusion criteria
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
|---|---|
|
Subjects aged 75 years and over admitted to a hospital ward following a hip fracture
Subjects aged 75 years and over, admitted to a hospital service following a hip fracture (per trochanteric or femoral neck) and having received surgical treatment (osteosynthesis or arthroplasty).
|
New Mobility Score (NMS), Measure of Functional Independence (MIF), Cumulated Ambulation Score (CAS), Mini-Mental State Examination (MMSE).
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Inter-rater reliability of the New Mobility Score (NMS)
기간: Within 7 days following the fracture surgery
|
The New Mobility Score (NMS) assesses mobility in three domains (indoors, outdoors, and while shopping).
For each domain, a score ranging from 0 (unable to perform the task) to 3 (able to perform the task independently) is assigned, with a total score ranging from 0 to 9. A score of ≤6 indicates functional impairment, whereas a score of >6 indicates a high pre-fracture level of mobility in patients with hip fracture.
The NMS will be rated by a physiotherapist and an adapted physical activity (APA) instructor.
|
Within 7 days following the fracture surgery
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Internal consistency of the New Mobility Score (NMS)
기간: Within 7 days following the fracture surgery
|
Internal consistency of the New Mobility Score (NMS) items.
|
Within 7 days following the fracture surgery
|
|
Convergent validity of the New Mobility Score (NMS) with other functional independence scales, cognitive status and age.
기간: Within 7 days following the fracture surgery
|
Correlation between the New Mobility Score (NMS) and:
|
Within 7 days following the fracture surgery
|
|
Predictive validity of mortality at postoperative day 30.
기간: Within 30 days following the fracture surgery
|
Correlation between the New Mobility Score (NMS) and vital status at postoperative day 30.
|
Within 30 days following the fracture surgery
|
|
Discriminatory validity based on place of residence.
기간: Within 7 days following the fracture surgery
|
Comparison of the New Mobility Score (NMS) according to pre-fracture living arrangements: living alone versus living in a nursing home/with family.
|
Within 7 days following the fracture surgery
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- 69HCL25_0571
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .